JENNIFER WIMS-MADDEN: Open Payments
NPI 1245585710 · PONTIAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,385 in 73 payments from 14 companies in 2025. Trend: 2023 $2,768 · 2024 $6,521 · 2025 $14,385
Speaker / faculty: $9,851Food & beverage: $3,149Travel & lodging: $990Consulting: $395
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $12,038 |
| Vanda Pharmaceuticals Inc. | 6 | $377 |
| E.R. Squibb & Sons, L.L.C. | 9 | $370 |
| Otsuka America Pharmaceutical, Inc. | 5 | $310 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $310 |
| Lundbeck LLC | 5 | $293 |
| Axsome Therapeutics, Inc. | 4 | $263 |
| ABBVIE INC. | 11 | $153 |
| Alkermes, Inc. | 1 | $120 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
Products named: AUSTEDO XR, REXULTI, FANAPT, COBENFY, CAPLYTA, Auvelity, VRAYLAR, UZEDY.
Industry payments across MI — which companies pay providers there.
